Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review.

Safy M, de Hair MJH, Jacobs JWG, Buttgereit F, Kraan MC, van Laar JM.

PLoS One. 2017 Dec 21;12(12):e0188810. doi: 10.1371/journal.pone.0188810. eCollection 2017. Review.

2.

Polymorphisms in the multidrug-resistance 1 gene related to glucocorticoid response in rheumatoid arthritis treatment.

Cuppen BV, Pardali K, Kraan MC, Marijnissen AC, Yrlid L, Olsson M, Bijlsma JW, Lafeber FP, Fritsch-Stork RD.

Rheumatol Int. 2017 Apr;37(4):531-536. doi: 10.1007/s00296-017-3653-1. Epub 2017 Jan 28.

3.

Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.

Lebre MC, Jonckheere CL, Kraan MC, van Kuijk AW, Bos JD, de Rie M, Gerlag DM, Tak PP.

Arthritis Res Ther. 2012 Sep 24;14(5):R200. doi: 10.1186/ar4038.

4.

CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial.

van Kuijk AW, Vergunst CE, Gerlag DM, Bresnihan B, Gomez-Reino JJ, Rouzier R, Verschueren PC, van der Leij C, Maas M, Kraan MC, Tak PP.

Ann Rheum Dis. 2010 Nov;69(11):2013-6. doi: 10.1136/ard.2010.131235. Epub 2010 Aug 6. Erratum in: Ann Rheum Dis. 2013 Apr;72(4):630. van de Leij, Christiaan [corrected to van der Leij, Christiaan].

PMID:
20693270
5.

Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.

van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL, van der Laken CJ, Lems WF, Scheper RJ, Dijkmans BA, Jansen G.

Arthritis Rheum. 2009 Mar;60(3):669-77. doi: 10.1002/art.24354.

6.

Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.

van der Heijden JW, Oerlemans R, Dijkmans BA, Qi H, van der Laken CJ, Lems WF, Jackman AL, Kraan MC, Tak PP, Ratnam M, Jansen G.

Arthritis Rheum. 2009 Jan;60(1):12-21. doi: 10.1002/art.24219.

7.

Clinical identification and treatment of a rapidly progressing disease state in patients with rheumatoid arthritis.

Emery P, McInnes IB, van Vollenhoven R, Kraan MC.

Rheumatology (Oxford). 2008 Apr;47(4):392-8. Epub 2007 Dec 18. Review.

PMID:
18094000
8.

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.

Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, Vos K, Lems WF, Wolbink GJ, Sijpkens D, Dijkmans BA, Tak PP.

Ann Rheum Dis. 2008 Aug;67(8):1139-44. Epub 2007 Nov 29.

9.

Quantitative image analysis of synovial tissue.

van der Hall PO, Kraan MC, Tak PP.

Methods Mol Med. 2007;135:121-43.

PMID:
17951656
10.

Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients.

Tchetverikov I, Kraan MC, van El B, Hanemaaijer R, DeGroot J, Huizinga TW.

Ann Rheum Dis. 2008 Jan;67(1):128-30. Epub 2007 Sep 17.

PMID:
17875551
11.

Pretreatment macrophage infiltration of the synovium predicts the clinical effect of both radiation synovectomy and intra-articular glucocorticoids.

Jahangier ZN, Jacobs JW, Kraan MC, Wenting MJ, Smeets TJ, Bijlsma JW, Lafeber FP, Tak PP.

Ann Rheum Dis. 2006 Oct;65(10):1286-92. Epub 2006 Apr 20.

12.

Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis.

Goedkoop AY, de Rie MA, Teunissen MB, Picavet DI, van der Hall PO, Bos JD, Tak PP, Kraan MC.

Arch Dermatol Res. 2005 Aug;297(2):51-9. Epub 2005 Oct 8.

PMID:
16012877
13.

Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes.

Berckmans RJ, Nieuwland R, Kraan MC, Schaap MC, Pots D, Smeets TJ, Sturk A, Tak PP.

Arthritis Res Ther. 2005;7(3):R536-44. Epub 2005 Mar 1.

14.

Identification of the epidermal growth factor-TM7 receptor EMR2 and its ligand dermatan sulfate in rheumatoid synovial tissue.

Kop EN, Kwakkenbos MJ, Teske GJ, Kraan MC, Smeets TJ, Stacey M, Lin HH, Tak PP, Hamann J.

Arthritis Rheum. 2005 Feb;52(2):442-50.

15.

Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis.

Gerlag DM, Haringman JJ, Smeets TJ, Zwinderman AH, Kraan MC, Laud PJ, Morgan S, Nash AF, Tak PP.

Arthritis Rheum. 2004 Dec;50(12):3783-91.

16.

Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP.

Ann Rheum Dis. 2005 Jun;64(6):834-8. Epub 2004 Dec 2.

17.

The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.

Vossenaar ER, Smeets TJ, Kraan MC, Raats JM, van Venrooij WJ, Tak PP.

Arthritis Rheum. 2004 Nov;50(11):3485-94.

18.

Tumour necrosis factor alpha blockade in treatment resistant pigmented villonodular synovitis.

Kroot EJ, Kraan MC, Smeets TJ, Maas M, Tak PP, Wouters JM.

Ann Rheum Dis. 2005 Mar;64(3):497-9. Epub 2004 Aug 5.

19.
20.

Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.

Goedkoop AY, Kraan MC, Teunissen MB, Picavet DI, de Rie MA, Bos JD, Tak PP.

Ann Rheum Dis. 2004 Jul;63(7):769-73.

21.

Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis.

Kraan MC, Smeets TJ, van Loon MJ, Breedveld FC, Dijkmans BA, Tak PP.

Ann Rheum Dis. 2004 Sep;63(9):1056-61. Epub 2004 Apr 28.

22.

T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis.

Kraan MC, Haringman JJ, Weedon H, Barg EC, Smith MD, Ahern MJ, Smeets TJ, Breedveld FC, Tak PP.

Ann Rheum Dis. 2004 May;63(5):483-8.

23.

Alefacept therapy reduces the effector T-cell population in lesional psoriatic epidermis.

Goedkoop AY, de Rie MA, Picavet DI, Kraan MC, Dinant HJ, van Kuijk AW, Tak PP, Bos JD, Teunissen MB.

Arch Dermatol Res. 2004 Apr;295(11):465-73. Epub 2004 Feb 14.

PMID:
14968366
24.

Activation of the STAT1 pathway in rheumatoid arthritis.

Kasperkovitz PV, Verbeet NL, Smeets TJ, van Rietschoten JG, Kraan MC, van der Pouw Kraan TC, Tak PP, Verweij CL.

Ann Rheum Dis. 2004 Mar;63(3):233-9.

25.

A woman with a lobar infiltrate due to psittacosis detected by polymerase chain reaction.

Heddema ER, Kraan MC, Buys-Bergen HE, Smith HE, Wertheim-van Dillen PM.

Scand J Infect Dis. 2003;35(6-7):422-4.

PMID:
12953962
27.

Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues.

van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL.

Arthritis Rheum. 2003 Aug;48(8):2132-45.

28.

Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis.

Haringman JJ, Kraan MC, Smeets TJ, Zwinderman KH, Tak PP.

Ann Rheum Dis. 2003 Aug;62(8):715-21.

30.

Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism.

Berckmans RJ, Nieuwland R, Tak PP, Böing AN, Romijn FP, Kraan MC, Breedveld FC, Hack CE, Sturk A.

Arthritis Rheum. 2002 Nov;46(11):2857-66.

31.

Alefacept treatment in psoriatic arthritis: reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis.

Kraan MC, van Kuijk AW, Dinant HJ, Goedkoop AY, Smeets TJ, de Rie MA, Dijkmans BA, Vaishnaw AK, Bos JD, Tak PP.

Arthritis Rheum. 2002 Oct;46(10):2776-84.

32.

Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial.

Choy EH, Panayi GS, Emery P, Madden S, Breedveld FC, Kraan MC, Kalden JR, Rascu A, Brown JC, Rapson N, Johnston JM.

Rheumatology (Oxford). 2002 Oct;41(10):1142-8.

PMID:
12364634
33.
34.

Decrease in synovial cellularity and cytokine expression after autologous stem cell transplantation in patients with juvenile idiopathic arthritis.

Brinkman DM, ten Cate R, Vossen JM, Smeets TJ, Kraan MC, Tak PP.

Arthritis Rheum. 2002 Apr;46(4):1121-3. No abstract available.

35.

Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging.

Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O'Connor PJ, Ridgway JP, Gibbon WW, Breedveld FC, Tak PP, Emery P.

Arthritis Rheum. 2002 Feb;46(2):366-72.

36.

Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis.

Katrib A, Tak PP, Bertouch JV, Cuello C, McNeil HP, Smeets TJ, Kraan MC, Youssef PP.

Rheumatology (Oxford). 2001 Sep;40(9):988-94.

PMID:
11561108
38.

Treatment-induced remission in rheumatoid arthritis patients is characterized by a reduction in macrophage content of synovial biopsies.

Smith MD, Kraan MC, Slavotinek J, Au V, Weedon H, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ.

Rheumatology (Oxford). 2001 Apr;40(4):367-74.

PMID:
11312372
39.

The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8).

Kraan MC, Patel DD, Haringman JJ, Smith MD, Weedon H, Ahern MJ, Breedveld FC, Tak PP.

Arthritis Res. 2001;3(1):65-71. Epub 2000 Nov 9.

40.

Measurement of cytokine and adhesion molecule expression in synovial tissue by digital image analysis.

Kraan MC, Smith MD, Weedon H, Ahern MJ, Breedveld FC, Tak PP.

Ann Rheum Dis. 2001 Mar;60(3):296-8.

43.

Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis.

Stahl HD, Hubner B, Seidl B, Liebert UG, van der Heijden IM, Wilbrink B, Kraan MC, Emmrich F, Tak PP.

Ann Rheum Dis. 2000 May;59(5):342-6.

44.

The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis.

Smeets TJ, Dayer JM, Kraan MC, Versendaal J, Chicheportiche R, Breedveld FC, Tak PP.

Arthritis Rheum. 2000 Feb;43(2):270-4.

45.

Quantification of the cell infiltrate in synovial tissue by digital image analysis.

Kraan MC, Haringman JJ, Ahern MJ, Breedveld FC, Smith MD, Tak PP.

Rheumatology (Oxford). 2000 Jan;39(1):43-9.

PMID:
10662872
46.

Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis.

Kraan MC, Haringman JJ, Post WJ, Versendaal J, Breedveld FC, Tak PP.

Rheumatology (Oxford). 1999 Nov;38(11):1074-80.

PMID:
10556258
48.

The effects of interferon beta treatment on arthritis.

Tak PP, Hart BA, Kraan MC, Jonker M, Smeets TJ, Breedveld FC.

Rheumatology (Oxford). 1999 Apr;38(4):362-9.

PMID:
10378715
49.

The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA).

Tak PP, Spaeny-Dekking L, Kraan MC, Breedveld FC, Froelich CJ, Hack CE.

Clin Exp Immunol. 1999 May;116(2):366-70.

50.

p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis.

Tak PP, Smeets TJ, Boyle DL, Kraan MC, Shi Y, Zhuang S, Zvaifler NJ, Breedveld FC, Firestein GS.

Arthritis Rheum. 1999 May;42(5):948-53.

Supplemental Content

Loading ...
Support Center